Cidara Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.39 | -$2.39 | -$2.39 |
| Q2 2024 | 1 | -$4.10 | -$4.10 | -$4.10 |
| Q3 2024 | 2 | -$4.25 | -$4.25 | -$4.25 |
| Q4 2024 | 1 | -$3.75 | -$3.75 | -$3.75 |
| Q1 2025 | 1 | -$4.66 | -$4.66 | -$4.66 |
| Q2 2025 | 1 | -$4.08 | -$4.08 | -$4.08 |
| Q3 2025 | 1 | -$3.26 | -$3.26 | -$3.26 |
| Q4 2025 | 1 | -$1.72 | -$1.72 | -$1.72 |
Cidara Therapeutics, Inc. Earnings Date And Information
Cidara Therapeutics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-2.38 earnings per share for the quarter, topping analysts' consensus estimates of $-4.25 by $1.87. The company had revenue of 0 for the quarter and had revenue of 63.91 M for the year. Cidara Therapeutics, Inc. has generated $-5 earnings per share over the last year ($-5.25 diluted earnings per share) and currently has a price-to-earnings ratio of -729.28. Cidara Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Cidara Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$4.25 | -$0.00 | 4.25 | $433,333 | $0 |
| 08/13/2024 | Q2 2024 | -$3.94 | -$19.59 | -15.65 | $1.30 M | $302,000 |
| 05/15/2024 | Q1 2024 | -$1.50 | -$2.28 | -0.78 | $8.46 M | |
| 04/22/2024 | Q4 2023 | -$1.25 | $17.58 M | |||
| 11/02/2023 | Q3 2023 | -$2.80 | -$1.81 | 0.99 | $8.14 M | $12.72 M |
| 08/03/2023 | Q2 2023 | -$1.60 | -$2.80 | -1.2 | $11.55 M | $7.61 M |
| 05/11/2023 | Q1 2023 | $1.20 | $0.63 | -0.57 | $25.99 M | |
| 03/23/2023 | Q4 2022 | -$0.20 | -$3.72 | -3.52 | $10.22 M | |
| 11/03/2022 | Q3 2022 | $6.00 | $3.39 | -2.61 | $28.35 M | $40.74 M |
| 08/09/2022 | Q2 2022 | -$5.60 | -$4.98 | 0.62 | $6.21 M | $6.22 M |
| 05/11/2022 | Q1 2022 | -$5.20 | -$5.41 | -0.21 | $7.11 M | |
| 03/07/2022 | Q4 2021 | -$6.60 | -$5.22 | 1.38 | $7.23 M | |
| 11/10/2021 | Q3 2021 | -$7.40 | -$7.40 | 0 | $2.94 M | $7.08 M |
| 08/12/2021 | Q2 2021 | -$5.40 | $3.62 | 9.02 | $12.13 M | $32.86 M |
| 05/13/2021 | Q1 2021 | -$3.40 | -$8.72 | -5.32 | $2.41 M | |
| 02/25/2021 | Q4 2020 | -$2.80 | -$9.80 | -7 | $3.73 M | |
| 11/05/2020 | Q3 2020 | -$9.60 | -$8.16 | 1.44 | $4.89 M | $2.42 M |
| 08/13/2020 | Q2 2020 | -$4.80 | -$9.00 | -4.2 | $5.29 M | $3.39 M |
| 05/13/2020 | Q1 2020 | -$6.80 | -$7.68 | -0.88 | $2.53 M | |
| 03/03/2020 | Q4 2019 | -$5.80 | -$8.43 | -2.63 | $1.82 M |
Cidara Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Cidara Therapeutics, Inc.'s earnings date?
Cidara Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
Did Cidara Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Cidara Therapeutics, Inc. (:CDTX) reported $-2.38 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.25 by $1.87.
-
How can I listen to Cidara Therapeutics, Inc.'s earnings conference call?
The conference call for Cidara Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Cidara Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Cidara Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Cidara Therapeutics, Inc. generate each year?
Cidara Therapeutics, Inc. (:CDTX) has a recorded annual revenue of $63.91 M.
-
How much profit does Cidara Therapeutics, Inc. generate each year?
Cidara Therapeutics, Inc. (:CDTX) has a recorded net income of $63.91 M. Cidara Therapeutics, Inc. has generated $-5.25 earnings per share over the last four quarters.
-
What is Cidara Therapeutics, Inc.'s price-to-earnings ratio?
Cidara Therapeutics, Inc. (:CDTX) has a price-to-earnings ratio of -729.28 and price/earnings-to-growth ratio is 3.54.
